North-East Health Care Investment ApS - CVR: 36935545

2022, EUR

31.03.2023

Bruttoresultat

-37.488

Primær drift

Na.

Årets resultat

-51.774

Aktiver

6.824'

Kortfristede aktiver

42.934

Egenkapital

6.313'

Afkastningsgrad

0 %

Soliditetsgrad

93 %

Likviditetsgrad

8 %

Resultat

31.03.2023

Årsrapport	2022 31.03.2023	2021 01.04.2022	2020 06.04.2021	2019 07.04.2020	2018 12.04.2019	2017 12.04.2018	2016 21.04.2017	2015 21.04.2016
Nettoomsætning
Bruttoresultat	-37.488	-7.690	-61.421	-961.648	-7.316	-8.983	436	-12.500
Resultat af primær drift	0	0	0	0	0	0	0	0
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0	0	0	0	0
Finansielle indtægter	0	0	5.394	1.584.210	166.914	156.743	187.098	27.778
Finansieringsomkostninger	-20.148	-21.918	-180.293	-40.240	-4.005	-792	-921	0
Andre finansielle omkostninger	0	0	0	0	0	0	0	0
Resultat før skat	-57.636	-29.608	-236.320	582.322	155.593	146.968	186.613	15.278
Resultat	-51.774	-23.082	-196.019	248.400	121.363	114.635	145.558	11.706
Forslag til udbytte	0	0	0	0	0	0	0	0

Aktiver

31.03.2023

Årsrapport	2022 31.03.2023	2021 01.04.2022	2020 06.04.2021	2019 07.04.2020	2018 12.04.2019	2017 12.04.2018	2016 21.04.2017	2015 21.04.2016
Kortfristede varebeholdninger	0	0	0	0	0	0	0	0
Kortfristede tilgodehavender fra salg og tjenesteydelser	41.509	39.573	40.301	33.892.476	4.282.603	4.115.689	0	5.011.667
Likvider	1.425	896	10.108	4.434.602	1.151.139	1.194.793	5.203.319	16.111
Kortfristede aktiver	42.934	40.469	50.409	38.327.078	5.433.742	5.310.482	5.203.319	5.027.778
Immaterielle aktiver og goodwill	0	0	0	0	0	0	0	0
Finansielle anlægsaktiver	6.780.648	6.767.630	5.264.136	0	0	0	0	0
Materielle aktiver	0	0	0	0	0	0	0	0
Langfristede aktiver	6.780.648	6.767.630	5.264.136	0	0	0	0	0
Aktiver	6.823.582	6.808.099	5.314.545	38.327.078	5.433.742	5.310.482	5.203.319	5.027.778

Aktiver

31.03.2023

Passiver

31.03.2023

Årsrapport	2022 31.03.2023	2021 01.04.2022	2020 06.04.2021	2019 07.04.2020	2018 12.04.2019	2017 12.04.2018	2016 21.04.2017	2015 21.04.2016
Forslag til udbytte	0	0	0	0	0	0	0	0
Egenkapital	6.312.918	6.364.692	4.887.773	37.974.406	5.393.262	5.271.899	5.157.264	5.011.706
Hensatte forpligtelser	0	0	0	0	0	0	0	0
Langfristet gæld til banker	0	0	0	0	0	0	0	0
Anden langfristet gæld	0	0	0	0	0	0	0	0
Leverandører af varer og tjenesteydelser	4.548	4.287	2.520	18.750	6.250	6.250	5.000	12.500
Kortfristede forpligtelser	510.664	443.407	426.772	352.672	40.480	38.583	46.055	16.072
Gældsforpligtelser	510.664	443.407	426.772	352.672	40.480	38.583	46.055	16.072
Forpligtelser	510.664	443.407	426.772	352.672	40.480	38.583	46.055	16.072
Passiver	6.823.582	6.808.099	5.314.545	38.327.078	5.433.742	5.310.482	5.203.319	5.027.778

Passiver

31.03.2023

Nøgletal

31.03.2023

Årsrapport	2022 31.03.2023	2021 01.04.2022	2020 06.04.2021	2019 07.04.2020	2018 12.04.2019	2017 12.04.2018	2016 21.04.2017	2015 21.04.2016
Afkastningsgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Dækningsgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Egenkapitals-forretning	-0,8 %	-0,4 %	-4,0 %	0,7 %	2,3 %	2,2 %	2,8 %	0,2 %
Payout-ratio	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	Na.	Na.	Na.	Na.	Na.	Na.	Na.	Na.
Soliditestgrad	92,5 %	93,5 %	92,0 %	99,1 %	99,3 %	99,3 %	99,1 %	99,7 %
Likviditetsgrad	8,4 %	9,1 %	11,8 %	10.867,6 %	13.423,3 %	13.763,8 %	11.298,1 %	31.282,8 %

Resultat

31.03.2023

Gæld

31.03.2023

Årsrapport

31.03.2023

Nyeste:01.01.2022- 31.12.2022(offentliggjort: 31.03.2023)

Information om virksomhedens regnskabsklasse:The annual report is presented in accordance with the provisions of the Danish Financial Statements Act (Årsregnskabsloven) for enterprises in reporting class B with application of provisions for a higher reporting class.

Beretning

31.03.2023

Dato for ledelsens godkendelse af årsrapporten:2023-03-31

Beskrivelse af usikkerhed ved indregning eller måling:Uncertainty concerning recognition and measurement The company, together with other well-established investors, has made investments in 2 biotech companies. Both biotech companies are in the initial development phase, characterized as costly and also having some uncertainty regarding a possible future potential in their underlying development projects. The management is aware of this derived uncertainty concerning recognition and measurement of these investments. By 31. 12. 22 management has not found any indication of impairment loss, meaning the investments are recognized at cost. Management is aware of the risk of their investments and seeks to minimize the risk involved with the individual companies.

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:We have on this day presented the annual report for the financial year 01. 01. 22 - 31. 12. 22 for North-East Health Care Investment ApS.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:Primary activities The company's activities comprise of directly or indirectly possesing share in other companies and to invest in companies, securities and other related activities, decides by the management.